Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors (Q35800291)
Jump to navigation
Jump to search
scientific article published on 22 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors |
scientific article published on 22 January 2014 |
Statements
1 reference
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors (English)
1 reference
Edward Sausville
1 reference
Patricia Lorusso
1 reference
Michael Carducci
1 reference
Judith Carter
1 reference
Mary F Quinn
1 reference
Lisa Malburg
1 reference
Nilofer Azad
1 reference
David Cosgrove
1 reference
Richard Knight
1 reference
Peter Barker
1 reference
Sonya Zabludoff
1 reference
Felix Agbo
1 reference
Patricia Oakes
1 reference
Adrian Senderowicz
1 reference
22 January 2014
1 reference
1 reference
539-549
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference